Quote:
Originally Posted by Conductor71
We have what looks like a very promising disease modifying treatment that as a natural substance appears to be more important than dopamine loss and this was published two years ago.
|
I am pretty sure disease modifying meds arrived:
https://www.michaeljfox.org/research...derisking.html
These are 4 companies working on targeting alpha-synuclien. Most of them just try to reduce a-synuclein in the brain. One of them is capable of unfolding the toxic aggregates to their normal state (and test on mice showed they actually got better --> 41 % improvement in motor skills in 6 months). The disease modifying meds are here, but they just need to be tested on safety. I almost dare to put my arm in the fire for this.
Quote:
Originally Posted by Conductor71
Is anyone else wondering why we do not know about this and feeling slightly punked? No one in the industry saw this as news worthy?
|
I had the same feeling when I first found out about this. The same for Alzheimer. This TauRx Pharmaceuticals achieved 80 % reduction in disease progression in a quite important clinical phase II. But they never speak about this. Then some researcher finds that K2 improved PD in fruit flies and suddenly this is the BIG news.
